The Latest Analyst Ratings for Inspire Medical Systems
Portfolio Pulse from Benzinga Insights
Inspire Medical Systems (NYSE:INSP) received 9 analyst ratings in the last quarter, with 5 bullish, 2 somewhat bullish, and 2 indifferent. No bearish ratings were reported. The average 12-month price target for INSP is $225.22, with a high of $340.00 and a low of $159.00. This target has decreased by 26.16% from the previous target of $305.00. Analyst ratings are opinions on stock performance and are updated quarterly.
December 13, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inspire Medical Systems has a majority of positive analyst ratings and a decreased average price target of $225.22, suggesting mixed sentiment.
The positive analyst ratings indicate optimism, which could support the stock price. However, the significant decrease in the average price target may reflect concerns about future performance, potentially limiting any positive impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100